View in EDS HTML Full Text PDF Full Text

Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.

Saved in:
Bibliographic Details
Title: Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
Authors: Mousavi Khorshidi, Mohadese Sadat1 (AUTHOR), Seeleuthner, Yoann2,3 (AUTHOR), Chavoshzadeh, Zahra4 (AUTHOR), Behfar, Maryam5,6 (AUTHOR), Hamidieh, Amir Ali5,6 (AUTHOR), Alimadadi, Hosein7 (AUTHOR), Sherkat, Roya8 (AUTHOR), Momen, Tooba9 (AUTHOR), Behniafard, Nasrin10,11 (AUTHOR), Eskandarzadeh, Shabnam12 (AUTHOR), Mansouri, Mahboubeh4 (AUTHOR), Behnam, Mahdiyeh13,14 (AUTHOR), Mahdavi, Mohadese1 (AUTHOR), Heydarazad Zadeh, Maryam4 (AUTHOR), Shokri, Mehdi15 (AUTHOR), Alizadeh, Fatemeh1 (AUTHOR), Movahedi, Mahshid1 (AUTHOR), Momenilandi, Mana2,3 (AUTHOR), Keramatipour, Mohammad16 (AUTHOR), Casanova, Jean-Laurent2,3,17 (AUTHOR)
Source: Journal of Clinical Immunology. Nov2023, Vol. 43 Issue 8, p1941-1952. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02719142
DOI:10.1007/s10875-023-01562-z